The U.S. experiences a minimum of 37,000 drug diversion incidents yearly, likely underreported. Just 40% of executives are very confident in their detection programs, with 67% planning to strengthen efforts in 2023.
- Improving inconsistent drug diversion processes: Historically, detecting drug diversion has been a labor-intensive process, with 71% of those surveyed spending at least eight hours on each investigation. Hospitals and ambulatory settings face challenges in maintaining consistent detection programs. The COVID-19 pandemic exacerbated these issues, with 69% of respondents attributing the increased difficulty in drug diversion detection to the higher presence of floating staff or contract workers.
